Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 19/4/2018
SIETES contiene 92257 citas

 1 a 20 de 55 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Montané E, Arellano AL, Sanz Y, Roca J, Farré M. Drug-related deaths in hospital inpatients: a retrospective cohort study. Br J Clin Pharmacol 2017;84:1. [Ref.ID 102184]
2. Cita con resumen
Anónimo. FDA announces list of off-patent drugs with no competition. DIA Daily 2017:1. [Ref.ID 101658]
3. Cita con resumen
Anónimo. Traitements des cancers de l'enfance: effets indésirables à long terme. Prescrire 2015;35:348-52. [Ref.ID 99136]
4. Cita con resumen
Anónimo. Neuropathies périphériques d'origine médicamenteuse. Prescrire 2013;33:269-75. [Ref.ID 95342]
5. Cita con resumen
Chabner BA. Drug shortages - A critical challenge for the generic-drug market. N Engl J Med 2011;365:2147-9. [Ref.ID 91926]
7. Cita con resumen
Henter JI, Chow CB, Leung C-W, Lau Y-L. Cytotoxic therapy for severe avian influenza A (H5N1) infection. Lancet 2006;367:870-3. [Ref.ID 76471]
8. Cita con resumen
Jackman DM, Johnson BE. Small-cell lung cancer. Lancet 2005;366:1385-96. [Ref.ID 75164]
9.Tiene citas relacionadas
Pedersen-Bjergaard J. Insights into leukemogenesis from therapy-related leukemia. N Engl J Med 2005;352:1591-4. [Ref.ID 73407]
10.Tiene citas relacionadas Cita con resumen
Mistry AR, Felix CA, Whitmarsh RJ, Mason A, Reiter A, Cassinat B, Parry A, Walz C, Wiemels JL, Segal MR, Adès L, Blair IA, Osheroff N, Peniket A J, Lafage-Pochitaloff M, Cross NCP, Chomienne C, Solomon E, Fenaux P, Grimwade D. DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N Engl J Med 2005;352:1529-38. [Ref.ID 73404]
11.Tiene citas relacionadas
Argiris A, Schiller JH. Can current treatments for advanced non-small-cell lung cancer be improved?. JAMA 2004;292:499-500. [Ref.ID 70883]
12.Tiene citas relacionadas Cita con resumen
Delbado C, Michiels S, Syz N, Soria JC, Le Chevalier T, Pignon J-P. Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer. A meta-analysis. JAMA 2004;292:470-84. [Ref.ID 70882]
14. Cita con resumen
Anónimo. Drug interactions with grapefruit juice. Med Lett Drugs Ther 2004;46:2-4. [Ref.ID 68641]
15.Tiene citas relacionadas
Wittes RE. Therapies for cancer in children - past successes, future challenges. N Engl J Med 2003;348:747-9. [Ref.ID 65096]
16.Tiene citas relacionadas
Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJH, Pritchard D J, Gebhardt MC, Dickman PS, Perlman E J, Meyers PA, Donaldson SS, Moore S, Rausen A R, Vietti TJ, Miser JS. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003;348:694-701. [Ref.ID 65089]
Verstappen CCP, Heimans JJ, Hoekman K, Postma T J. Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 2003;63:1549-63. [Ref.ID 64215]
18. Cita con resumen
Schmitz N, Pfistner B, Sextro M, Sieber M, Carella AM, Haenel M, Boissevain F, Zschaber R, Müller P, Kirchner H, Lohri A, Decker S, Koch B, Hasenclever D, Goldstone AH, Diehl V, for the German Hodgkin's Lymphoma Study Group (GHSG) and the Lymphoma Working Party of the European for Blood and Marrow Transplantation (EBMT). Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. Lancet 2002;359:2065-71. [Ref.ID 62646]
19.Tiene citas relacionadas Cita con resumen
Gambacorti-Passerini C. Decrease in unexplained psychotic reactions and encephalopathy. Lancet 2002;359:1777. [Ref.ID 61978]
20.Tiene citas relacionadas Cita con resumen
Rumiana B, Zhivko Z, Hideki O. Decrease in unexplained psychotic reactions and encephalopathy. Lancet 2002;359:1776-7. [Ref.ID 61977]
Seleccionar todas
 1 a 20 de 55 siguiente >>